Mimedx Group Inc (MDXG)
6.63 x 9 6.80 x 35
Post-market by (Cboe BZX)
6.88 -0.04 (-0.58%) 04/30/25 [NASDAQ]
6.63 x 9 6.80 x 35
Post-market 6.72 -0.16 (-2.33%) 17:20 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | MDXG | NVAX | SYRE | ||
| Company | Mimedx Group Inc | Novavax Inc | Spyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.89 | 6.30 | 14.79 | ||
| High | 7.00 | 6.76 | 15.45 | ||
| Low | 6.74 | 6.24 | 14.64 | ||
| Last | 6.88 | 6.67 | 15.23 | ||
| Change | -0.04 | +0.25 | +0.21 | ||
| % Change | -0.58% | +3.89% | +1.40% | ||
| Volume | 704,300 | 5,238,100 | 439,400 | ||
| 20-Day Average Volume | 552,490 | 7,623,750 | 802,345 | ||
| Previous Close | 6.92 | 6.42 | 15.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.90 | 6.35 | 13.53 | ||
| 20-Day Raw Stochastic | 31.50% | 59.29% | 88.34% | ||
| 20-Day Relative Strength | 41.19% | 48.09% | 47.86% | ||
| Weighted Alpha | -12.42 | -29.37 | -47.67 | ||
| Today's Opinion | 88% Sell | 80% Sell | 88% Sell | ||
| Previous Opinion | 72% Sell | 80% Sell | 88% Sell | ||
| Last Month's Opinion | 24% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.78% since 04/23/25 | -10.71% since 04/23/25 | +7.10% since 04/23/25 | ||
| Low | 6.68 on 04/25/25 | 6.12 on 04/25/25 | 13.83 on 04/25/25 | ||
| High | 7.07 on 04/29/25 | 7.49 on 04/24/25 | 15.45 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | -8.75% since 03/28/25 | -4.71% since 03/28/25 | -15.11% since 03/28/25 | ||
| Low | 6.48 on 04/11/25 | 5.01 on 04/10/25 | 10.91 on 04/09/25 | ||
| High | 7.75 on 04/02/25 | 7.81 on 04/23/25 | 17.67 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -22.78% since 01/30/25 | -25.97% since 01/30/25 | -31.61% since 01/30/25 | ||
| Low | 6.48 on 04/11/25 | 5.01 on 04/10/25 | 10.91 on 04/09/25 | ||
| High | 8.98 on 01/31/25 | 9.18 on 01/31/25 | 24.83 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | +20.91% since 10/30/24 | -32.22% since 10/30/24 | -55.42% since 10/30/24 | ||
| Low | 6.22 on 10/31/24 | 5.01 on 04/10/25 | 10.91 on 04/09/25 | ||
| High | 10.14 on 12/10/24 | 11.55 on 01/07/25 | 40.26 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,019,773 | 1,032,618 | 905,346 | ||
| Shares Outstanding, K | 147,366 | 160,844 | 60,276 | ||
| Annual Sales | 348,880,000 | 682,160,000 | 0 | ||
| Annual Net Income | 42,420,000 | -187,500,000 | -208,020,000 | ||
| Last Quarter Sales | 92,910,000 | 88,310,000 | 0 | ||
| Last Quarter Net Income | 7,440,000 | -81,030,000 | -56,300,000 | ||
| 60-Month Beta | 1.74 | 3.15 | 3.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 02/26/25 | -0.51 on 02/27/25 | -0.81 on 02/27/25 | ||
| Latest Earnings Date | 04/30/25 | 05/09/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.55 | 0.00 | 0.00 | ||